M Baum

2.8k total citations
24 papers, 481 citations indexed

About

M Baum is a scholar working on Oncology, Genetics and Cancer Research. According to data from OpenAlex, M Baum has authored 24 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Genetics and 5 papers in Cancer Research. Recurrent topics in M Baum's work include Estrogen and related hormone effects (7 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Risks and Factors (3 papers). M Baum is often cited by papers focused on Estrogen and related hormone effects (7 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Risks and Factors (3 papers). M Baum collaborates with scholars based in United Kingdom, Italy and Canada. M Baum's co-authors include Lesley Fallowfield, Roger A’Hern, J. Houghton, Nigel Sacks, N Sacks, Jo Marsden, Malcolm Whitehead, Mary O’Brien, A. Jones and David O. Cosgrove and has published in prestigious journals such as British Journal of Cancer, Fertility and Sterility and European Journal of Cancer.

In The Last Decade

M Baum

23 papers receiving 456 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M Baum United Kingdom	10	266	253	140	79	73	24	481
Elwine Halewijn Netherlands	8	159 0.6×	374 1.5×	109 0.8×	101 1.3×	20 0.3×	16	711
M. Ziller Germany	12	182 0.7×	317 1.3×	70 0.5×	33 0.4×	27 0.4×	26	586
D B Thomas United States	11	190 0.7×	336 1.3×	100 0.7×	67 0.8×	25 0.3×	17	731
Richard N. Watkins United States	4	206 0.8×	164 0.6×	39 0.3×	101 1.3×	22 0.3×	8	475
Nancylee J. Friedlander United States	7	105 0.4×	137 0.5×	63 0.5×	72 0.9×	18 0.2×	9	341
W. Li United States	8	90 0.3×	428 1.7×	106 0.8×	31 0.4×	54 0.7×	9	682
T M Mack United States	4	215 0.8×	139 0.5×	61 0.4×	263 3.3×	19 0.3×	6	697
E. E. Calle United States	5	168 0.6×	201 0.8×	62 0.4×	104 1.3×	11 0.2×	5	436
A. Jones United Kingdom	9	172 0.6×	131 0.5×	63 0.5×	41 0.5×	10 0.1×	15	336
Shaneda Warren Andersen United States	13	120 0.5×	349 1.4×	59 0.4×	106 1.3×	49 0.7×	43	671

Countries citing papers authored by M Baum

Since Specialization

Citations

This map shows the geographic impact of M Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Baum more than expected).

Fields of papers citing papers by M Baum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Baum. The network helps show where M Baum may publish in the future.

Co-authorship network of co-authors of M Baum

This figure shows the co-authorship network connecting the top 25 collaborators of M Baum. A scholar is included among the top collaborators of M Baum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Baum. M Baum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baum, M, et al.. (2021). Utilizing biofeedback as a behavioral change strategy in overweight and obese cancer survivors to promote physical activity: A focus group analysis. 1 indexed citations

Baum, M. (2007). The dangers of complementary therapy. Breast Cancer Research. 9(S2). 2 indexed citations

Baum, M, Allan Hackshaw, J. Houghton, et al.. (2006). Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study. European Journal of Cancer. 42(7). 895–904. 70 indexed citations

Vaidya, Jayant S., M Baum, Samuele Massarut, et al.. (2006). 5 ORAL A very low recurrence rate is achieved by a targeted intraoperative radiotherapy (TARGIT) boost after breast conserving surgery for cancer. European Journal of Surgical Oncology. 32. S3–S3. 2 indexed citations

Jassem, Jacek, F. Jänicke, M Baum, et al.. (2004). The Hamburg statement: the partnership driving the European agenda on breast cancer. European Journal of Cancer. 40(12). 1810–1811. 16 indexed citations

Baum, M. (2002). The ATAC (rimidex™, amoxifen, lone or in ombination) adjuvant breast cancer trial in postmenopausal patients: factors influencing the success of patient recruitment. European Journal of Cancer. 38(15). 1984–1986. 21 indexed citations

Baum, M, et al.. (2001). Management of premenopausal women with early breast cancer. Is there a role for Goserelin?. UCL Discovery (University College London). 8 indexed citations

Marsden, Jo, Malcolm Whitehead, Roger A’Hern, M Baum, & Nigel Sacks. (2000). Are randomized trials of hormone replacement therapy in symptomatic women with breast cancer feasible?. Fertility and Sterility. 73(2). 292–299. 55 indexed citations

Baum, M, et al.. (1999). Using an interactive video disk in breast cancer patient support.. PubMed. 94(44). 52–5. 30 indexed citations

10.

Baum, M, et al.. (1998). Hormone Replacement Therapy in Women with Previous Breast Cancer. Trends in Endocrinology and Metabolism. 9(1). 32–38. 7 indexed citations

11.

Baum, M & J. Houghton. (1998). P99 Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer. European Journal of Cancer. 34. S39–S39. 7 indexed citations

12.

Houghton, J. & M Baum. (1998). Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer. European Journal of Cancer. 34. S83–S83. 4 indexed citations

13.

Powles, T.J., A. Jones, S. Ashley, et al.. (1994). The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Research and Treatment. 31(1). 73–82. 117 indexed citations

14.

Fernando, Indrajit, et al.. (1993). Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen. British Journal of Cancer. 67(4). 706–712. 15 indexed citations

15.

Fallowfield, Lesley, et al.. (1990). What are the Psychological Factors Influencing Attendance, Non-Attendance and Re-Attendance at a Breast Screening Centre?. Journal of the Royal Society of Medicine. 83(9). 547–551. 84 indexed citations

16.

Houghton, J., M Baum, & R Nissen-Meyer. (1988). Is there a role for perioperative adjuvant therapy in the treatment of early breast cancer?. PubMed. 14(3). 227–33. 1 indexed citations

17.

Baum, M, et al.. (1976). Delay in presentation of women with breast disease.. PubMed. 2(4). 327–31. 9 indexed citations

18.

Baum, M, et al.. (1973). Proceedings: macrophage phagocytic activity in patients with breast cancer.. PubMed. 60(11). 899–900. 5 indexed citations

19.

Baum, M & Brandon J. Fisher. (1972). Macrophage production in response to the growth of an experimental tumour.. PubMed. 59(11). 904–5. 2 indexed citations

20.

Baum, M, et al.. (1971). Treatment of early breast cancer: the organization of a 'national trial'.. PubMed. 58(11). 861–861. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact